Estimated reading time: 8 minutes
In recent years, more and more people have started to take medicine for weight loss. The use of GLP-1 medications for weight loss, which is the class of drug these fall under, has more than doubled since 2011! Originally designed to treat type 2 diabetes, these drugs have been proven to be incredibly effective in suppressing appetite and slowing down digestion. Two medications, Tirzepatide and Semaglutide, are leading options. If you are considering asking your doctor about these drugs, you should understand how they work, their benefits, and their differences. Here is a guide from PatientsLikeMe.
What is Tirzepatide?
Tirzepatide is sold under brand names like Zepbound (for weight loss) and Mounjaro (for type 2 diabetes). It is a once-weekly injection designed to help you lose weight and manage blood sugar levels. It works by targeting two hormones in your body:
- GIP (glucose-dependent insulinotropic polypeptide)
- GLP-1 (glucagon-like peptide-1)
These hormones increase in your body when you eat, helping to regulate insulin, reduce appetite, and slow down digestion.
By mimicking these hormones, Tirzepatide helps reduce hunger and keeps food in your stomach longer. This in turn makes you feel more full. This effect leads to lower calorie intake and weight loss. In clinical trials, patients lost significant weight over 72 weeks, with results varying by dosage.
- 16.1 kg (35.5 lbs) with 5 mg
- 22.2 kg (48.9 lbs) with 10 mg
- 23.6 kg (52.0 lbs) with 15 mg
When used for type 2 diabetes (Mounjaro), Tirzepatide improves blood sugar control by increasing insulin production and reducing sugar made by the liver. However, it's important to note that it should not be used for type 1 diabetes and may not be suitable for people with a history of pancreatitis.
Common Side Effects of Tirzepatide
The most common side effects include:
- Nausea
- Vomiting
- Digestive issues
More severe risks involve:
- Thyroid problems
- Kidney issues
- Allergic reactions
Always talk to your doctor about your medical history, including thyroid or pancreas conditions, before using Tirzepatide.
Benefits of Tirzepatide
As we mentioned there two main reasons individuals seek Tirzepatide, weight loss or type 2 diabetes treatment. According to a study, these are the benefits they found in patients using Tirzepatide.
- Glycosylated hemoglobin (HbA1c) reduction
- Weight loss
- Cardiovascular health
- A good lipoprotein profile
- Improvement in nonalcoholic steatohepatitis (NASH)
HbA1c Reduction
Glycosylated hemoglobin, or HbA1c, is a measure of how much sugar (glucose) is attached to hemoglobin, which is the protein in red blood cells that carries oxygen.
What does HbA1c tell us?
- It reflects your average blood sugar levels over the past two to three months.
- A higher HbA1c level indicates poorer blood sugar control, while a lower level shows better control.
What is HbA1c reduction?
- When a diabetes medication helps lower HbA1c levels, it means that the drug is effectively controlling blood sugar levels over time.
- Reducing HbA1c is important because lower levels are associated with a lower risk of diabetes-related complications, like heart disease, kidney damage, and nerve issues.
So, in simple terms, HbA1c reduction means getting better control of blood sugar over time, which is crucial for managing diabetes effectively.
Weight Loss
In that same clinical study, they explained how tirzepatide affected weight loss through the GLP-1 effect and the overall impact of both GIP and GLP-1.
- GLP-1 Effect: One of the hormones that tirzepatide targets, GLP-1, helps increase feelings of fullness (satiety). This can lead to reduced appetite and, consequently, weight loss.
- Overall Impact: By combining the actions of both GIP and GLP-1, tirzepatide not only improves blood sugar control but also promotes weight loss through its effects on appetite and fat metabolism.
So, tirzepatide aids in weight loss by enhancing the body's natural mechanisms that regulate hunger and fat storage.
Cardiovascular Health
The study also explained the cardiovascular health benefits for patients in the clinical study. It showed the differences in GLP-1 and GIP.
GLP-1 and Cardiovascular Health
- Beneficial Effects: GLP-1 (glucagon-like peptide-1) has shown positive effects on heart health and can help with various cardiovascular issues, not just diabetes.
- Presence in the Heart: GLP-1 receptors are found throughout the heart, including in all four chambers and specifically in the sino-atrial node (the part of the heart that controls the heartbeat).
- Protective Actions: GLP-1 receptor agonists (medications that mimic GLP-1) can prevent the development and worsening of atherosclerosis, which is the buildup of plaques in blood vessels that can lead to heart problems.
- Anti-Inflammatory Properties: These agonists also have anti-inflammatory effects, helping protect the heart and kidneys from damage.
GIP and Cardiovascular Health
- Functional Role: GIP (glucose-dependent insulinotropic polypeptide) receptors in the heart play a different but important role. While there is less research on GIP compared to GLP-1, it still has notable cardiovascular effects.
- Actions of GIP: GIP can increase heart rate, promote blood vessel dilation (widening), and help regulate blood flow.
- Anti-Atherosclerotic Activity: Animal studies suggest that GIP might help prevent atherosclerosis and reduce oxidative stress (which can damage cells) in blood vessels.
Although promising, more studies are needed to fully understand how GIP works in the cardiovascular system.
So, both GLP-1 and GIP have beneficial effects on cardiovascular health. GLP-1 is more established in its protective role against heart issues, while GIP shows potential benefits but needs further investigation. Together, they highlight the therapeutic possibilities beyond just managing diabetes, suggesting they could also play important roles in heart health.
A Good Lipoprotein Profile
A lipoprotein profile measures different types of fats (lipids) in the blood, including LDL (bad cholesterol), HDL (good cholesterol), and triglycerides. A good lipoprotein profile means having low levels of LDL and triglycerides and higher levels of HDL.
What is Semaglutide?
Semaglutide is marketed under the brand Wegovy for weight loss. It is another injectable medication taken once a week. Like Tirzepatide, Semaglutide also works by mimicking the GLP-1 hormone. It was initially used to treat type 2 diabetes under the brands Ozempic and Rybelsus. However, researchers found that it also leads to substantial weight loss, even for people without diabetes.
Semaglutide helps reduce appetite by influencing the brain’s hunger signals and slowing down how fast your stomach empties food. In a study, participants who used Semaglutide alongside diet and exercise lost around 15% of their body weight over 68 weeks, compared to only 2.4% with lifestyle changes alone. However, once people stop taking the medication, they often regain some weight.
Common Side Effects of Semaglutide
- Nausea
- Vomiting
- Diarrhea
- Stomach pain
- Fatigue
- Dizziness
- Headaches
People with a history of thyroid cancer, gallbladder disease, pancreatitis, or MEN2 should avoid using Semaglutide.
Comparing Tirzepatide and Semaglutide
Both Tirzepatide and Semaglutide are good weight loss options. They do, however, work slightly differently and have unique benefits.
| Tirzepatide (Zepbound/Mounjaro) | Semaglutide (Wegovy/Ozempic) | |
|---|---|---|
| Mechanism | Mimics both GIP and GLP-1 hormones | Mimics GLP-1 hormone only |
| Frequency | Once-weekly injection | Once-weekly injection |
| Approved Uses | Weight loss, type 2 diabetes | Weight loss, type 2 diabetes |
| Average Weight Loss | Up to 23.6 kg (52 lbs) in 72 weeks | 15% of body weight in 68 weeks |
| Side Effects | Nausea, vomiting, digestive issues, thyroid risks | Nausea, vomiting, stomach pain, thyroid risks |
| Suitable For | Adults with obesity or overweight, and type 2 diabetes | Adults with obesity or overweight |
| Risk of Regaining Weight | Some weight regain if stopped | Weight regain if medication is discontinued |
| Unique Benefits | Targets two hormones (GIP and GLP-1) for enhanced effects | FDA-approved specifically for weight management |
Which One is Right for You?
If you are considering Tirzepatide or Semaglutide for weight loss or managing type 2 diabetes, the decision comes down to your specific health needs and preferences.
- Tirzepatide may offer faster or more significant weight loss since it targets both GIP and GLP-1 hormones. It might be a good choice if you are looking for a more aggressive approach to managing both weight and blood sugar.
- Semaglutide is a simpler option that only targets the GLP-1 hormone. It does still deliver impressive weight loss results. It is widely available and approved for people without diabetes.
Starting Your Weight Loss Journey
Before starting either medication, talk to your doctor about your medical history, weight loss goals, and any potential risks. Both drugs have been life-changing for many people, but they are most effective when combined with diet, exercise, and long-term lifestyle changes. Join the PatientsLikeMe community to share your journey and gain support from others on a similar path!